Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & DohmefiledCriticalMerck Sharp & Dohme
Publication of ECSP003787ApublicationCriticalpatent/ECSP003787A/en
Se describen 3-tere-butil-7-(5-metilisoxazol-3-il)-2-(2-metil-2H-[1.2.4]triazol-3-ilmetoxi)pirazolo [1,5-d] [1.2.4]triazina, composiciones farmacéuticas que los comprenden, se usa para estimular la cognición y en procedimientos de tratamiento de sujetos que sufren cognición reducida.3-Tere-butyl-7- (5-methylisoxazol-3-yl) -2- (2-methyl-2H- [1.2.4] triazol-3-ylmethoxy) pyrazolo [1,5-d] [1.2 are described .4] triazine, pharmaceutical compositions that comprise them, is used to stimulate cognition and in treatment procedures for subjects suffering from reduced cognition.
ECSP0037871999-11-252000-11-24
A PIRAZOLOTRIAZINE REPLACED AS SELECTIVE INVESTED AGONISTS FOR THE GABA-A ALFA5 RECEPTOR SUBTIPE
ECSP003787A
(en)
SYSTEMS AND DEVICES FOR THE TREATMENT OF BONE FRACTURES OR BONE PATIENTS WITH THE HELP OF EXPANDABLE BODIES (OPTIONS), STERILE SET OF TOOLS FOR INTRODUCTION IN BONE (OPTIONS)
CYCLOALKYL DERIVATIVES AS INHIBITORS OF BONE RESORPTION AND VITRONECTIN RECEPTOR ANTAGONISTS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATION.
SUBSTANCES LIBRARY CONTAINING BICYCLE IMIDAZO-5-IL-AMINES AND / OR BICYCLIC 3-IL-AMINAS IMMEDITION, PROCEDURE FOR THE PREPARATION OF SUBSTANTIAL LIBRARY, AND USE OF SUBSTANCES OF THIS LIBRARY FOR THE PREPARATION OF DRUG PREPARATION
Use of escitalopram or a pharmaceutically acceptable salt thereof to prepare a drug useful in the treatment of social anxiety (divisional application 1799-00).